Study: NCT04142437

Intervention type: DRUG
Intervention: larotrectinib(Vitrakvi, BAY2757556)
Description: In the study, patients treated under local standard of care clinical practice; all decisions in terms of diagnostic procedures, treatments, management of the disease, and resource utilization are fully dependent on mutual agreement between the patient and the attending physician, without interference by the study initiator or study protocol

Intervention type: DRUG
Intervention: larotrectinib(Vitrakvi, BAY2757556)
Description: In the study, patients treated under local standard of care clinical practice; all decisions in terms of diagnostic procedures, treatments, management of the disease, and resource utilization are fully dependent on mutual agreement between the patient and the attending physician, without interference by the study initiator or study protocol

Intervention type: DRUG
Intervention: larotrectinib(Vitrakvi, BAY2757556)
Description: In the study, patients treated under local standard of care clinical practice; all decisions in terms of diagnostic procedures, treatments, management of the disease, and resource utilization are fully dependent on mutual agreement between the patient and the attending physician, without interference by the study initiator or study protocol

Intervention type: DRUG
Intervention: larotrectinib(Vitrakvi, BAY2757556)
Description: In the study, patients treated under local standard of care clinical practice; all decisions in terms of diagnostic procedures, treatments, management of the disease, and resource utilization are fully dependent on mutual agreement between the patient and the attending physician, without interference by the study initiator or study protocol

Intervention type: DRUG
Intervention: larotrectinib(Vitrakvi, BAY2757556)
Description: In the study, patients treated under local standard of care clinical practice; all decisions in terms of diagnostic procedures, treatments, management of the disease, and resource utilization are fully dependent on mutual agreement between the patient and the attending physician, without interference by the study initiator or study protocol

Intervention type: DRUG
Intervention: larotrectinib(Vitrakvi, BAY2757556)
Description: In the study, patients treated under local standard of care clinical practice; all decisions in terms of diagnostic procedures, treatments, management of the disease, and resource utilization are fully dependent on mutual agreement between the patient and the attending physician, without interference by the study initiator or study protocol

Intervention type: DRUG
Intervention: larotrectinib(Vitrakvi, BAY2757556)
Description: In the study, patients treated under local standard of care clinical practice; all decisions in terms of diagnostic procedures, treatments, management of the disease, and resource utilization are fully dependent on mutual agreement between the patient and the attending physician, without interference by the study initiator or study protocol

Intervention type: DRUG
Intervention: larotrectinib(Vitrakvi, BAY2757556)
Description: In the study, patients treated under local standard of care clinical practice; all decisions in terms of diagnostic procedures, treatments, management of the disease, and resource utilization are fully dependent on mutual agreement between the patient and the attending physician, without interference by the study initiator or study protocol